Label-free quantitative proteomics of CD133-positive liver cancer stem cells

BACKGROUND: CD133-positive liver cancer stem cells, which are characterized by their resistance to conventional chemotherapy and their tumor initiation ability at limited dilutions, have been recognized as a critical target in liver cancer therapeutics. In the current work, we developed a label-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Sheng-Ta, Tsou, Chih-Chiang, Mao, Wan-Yu, Chang, Wei-Chao, Han, Hsin-Ying, Hsu, Wen-Lian, Li, Chung-Leung, Shen, Chia-Ning, Chen, Chung-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576254/
https://www.ncbi.nlm.nih.gov/pubmed/23170877
http://dx.doi.org/10.1186/1477-5956-10-69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576254/
https://www.ncbi.nlm.nih.gov/pubmed/23170877
http://dx.doi.org/10.1186/1477-5956-10-69

Ejemplares similares